Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-119800
Filing Date
2024-11-01
Accepted
2024-11-01 07:04:51
Documents
1
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4265
  Complete submission text file 0000950170-24-119800.txt   5887
Mailing Address 9301 AMBERGLEN BOULEVARD, SUITE 100 C/O MOLECULAR TEMPLATES, INC. AUSTIN TX 78729
Business Address
Cutler Adam D. (Reporting) CIK: 0001722673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41837 | Film No.: 241417032

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)